Literature DB >> 17594326

Classical Parkinson disease versus Parkinson complex--reflections against staging and in favour of heterogeneity.

G Linazasoro1.   

Abstract

Pathological studies have prompted the idea that Parkinson disease (PD) is a multisystem disorder, which starts far away from the nigrostriatal dopamine system and it goes through a long pre-clinical period. Evidence from epidemiological research, functional imaging, olfaction and sleep studies provides support to this hypothesis. Accordingly, PD is seen as an homogeneous disease which sequentially affects different neural structures leading to a well-defined clinical picture. This concept, recently named PD complex, has deep theoretical and practical implications which raise some concerns. This report shows the concept of classical PD as opposed to PD complex. Although the relevance of the central argument concerning the PD complex concept is admitted, it needs to be fully proved before premature conclusions are drawn. In contrast, the notion of classical and clinically significant PD can explain many of the well-characterized pathological and clinical features of the disease and it gives support to the idea that the magic word in PD is variability.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17594326     DOI: 10.1111/j.1468-1331.2007.01853.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  4 in total

Review 1.  The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia.

Authors:  Walter J Schulz-Schaeffer
Journal:  Acta Neuropathol       Date:  2010-06-20       Impact factor: 17.088

2.  Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction.

Authors:  Thomas G Beach; Charles H Adler; LihFen Lue; Lucia I Sue; Jyothi Bachalakuri; Jonette Henry-Watson; Jeanne Sasse; Sarah Boyer; Scophil Shirohi; Reed Brooks; Jennifer Eschbacher; Charles L White; Haru Akiyama; John Caviness; Holly A Shill; Donald J Connor; Marwan N Sabbagh; Douglas G Walker
Journal:  Acta Neuropathol       Date:  2009-04-28       Impact factor: 17.088

Review 3.  Inflammation and α-synuclein's prion-like behavior in Parkinson's disease--is there a link?

Authors:  Carla M Lema Tomé; Trevor Tyson; Nolwen L Rey; Stefan Grathwohl; Markus Britschgi; Patrik Brundin
Journal:  Mol Neurobiol       Date:  2012-04-29       Impact factor: 5.590

Review 4.  Is Cell Death Primary or Secondary in the Pathophysiology of Idiopathic Parkinson's Disease?

Authors:  Walter J Schulz-Schaeffer
Journal:  Biomolecules       Date:  2015-07-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.